Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS)

Q: What does CUSIP 00461U105 represent in this 13F holders report?

CUSIP 00461U105 is the security identifier for ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share used to aggregate holder disclosures.

Q: How many institutions held ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share in Q4 2016?

100 institutional investors reported ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share for Q4 2016. Use the holders table for investor-level position and value details.

CUSIP: 00461U105

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class: Equity / Common Stock, $0.00001 par value per share
Shares outstanding: 121,058,810
Total 13F shares: 21,351,804
Share change: +3,436,354
Total reported value: $579,490,455
Price per share: $27.14
Number of holders: 100
Value change: +$95,769,317
Number of buys: 86
Number of sells: 14

Quarterly Holders Quick Answers

What is CUSIP 00461U105?
CUSIP 00461U105 identifies ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2017
Previous quarter: Q3 2016

Recent filing periods for CUSIP 00461U105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Vivo Capital, LLC	13F	Company	3.5%	4,191,397	$107,342,000	—	30 Sep 2016	13F
FMR LLC	13F	Company	2.2%	2,659,327	$68,105,000	—	30 Sep 2016	13F
FRANKLIN RESOURCES INC	13F	Company	1.3%	1,567,513	$40,144,000	—	30 Sep 2016	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	1.3%	1,547,152	$39,623,000	—	30 Sep 2016	13F
Rock Springs Capital Management LP	13F	Company	0.84%	1,016,000	$26,020,000	—	30 Sep 2016	13F
Cormorant Asset Management, LP	13F	Company	0.74%	901,286	$23,082,000	—	30 Sep 2016	13F
FIL Ltd	13F	Company	0.52%	625,713	$16,025,000	—	30 Sep 2016	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.36%	430,000	$11,012,000	—	30 Sep 2016	13F
VANGUARD GROUP INC	13F	Company	0.35%	425,487	$10,897,000	—	30 Sep 2016	13F
BlackRock Fund Advisors	13F	Company	0.22%	266,552	$6,826,000	—	30 Sep 2016	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.15%	182,935	$4,685,000	—	30 Sep 2016	13F
Ghost Tree Capital, LLC	13F	Company	0.14%	175,000	$4,482,000	—	30 Sep 2016	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.12%	140,000	$3,585,000	—	30 Sep 2016	13F
STATE STREET CORP	13F	Company	0.11%	132,060	$3,383,000	—	30 Sep 2016	13F
MARSHALL WACE, LLP	13F	Company	0.1%	120,800	$3,094,000	—	30 Sep 2016	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.1%	116,000	$2,971,000	—	30 Sep 2016	13F
NORTHERN TRUST CORP	13F	Company	0.09%	109,138	$2,795,000	—	30 Sep 2016	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.08%	99,202	$2,541,000	—	30 Sep 2016	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.06%	74,840	$1,917,000	—	30 Sep 2016	13F
HighTower Advisors, LLC	13F	Company	0.04%	51,886	$1,329,000	—	30 Sep 2016	13F
DEUTSCHE BANK AG\	13F	Company	0.04%	51,590	$1,321,000	—	30 Sep 2016	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.04%	51,145	$1,309,000	—	30 Sep 2016	13F
Bank of New York Mellon Corp	13F	Company	0.04%	46,733	$1,198,000	—	30 Sep 2016	13F
Nicholas Investment Partners, LP	13F	Company	0.04%	46,722	$1,197,000	—	30 Sep 2016	13F
Granite Point Capital Management, L.P.	13F	Company	0.03%	36,000	$922,000	—	30 Sep 2016	13F
BlackRock Investment Management, LLC	13F	Company	0.03%	34,895	$894,000	—	30 Sep 2016	13F
TOCQUEVILLE ASSET MANAGEMENT L.P.	13F	Company	0.03%	33,000	$845,000	—	30 Sep 2016	13F
Informed Momentum Co LLC	13F	Company	0.03%	31,967	$819,000	—	30 Sep 2016	13F
NORGES BANK	13F	Company	0.03%	33,170	$811,000	—	30 Sep 2016	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.02%	28,440	$728,000	—	30 Sep 2016	13F
Emerald Acquisition Ltd.	13F	Company	0.02%	27,096	$694,000	—	30 Sep 2016	13F
MORGAN STANLEY	13F	Company	0.02%	26,937	$690,000	—	30 Sep 2016	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.02%	24,531	$629,000	—	30 Sep 2016	13F
E. E. Geduld	13F	Individual	0.02%	22,500	$576,000	—	30 Sep 2016	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.02%	20,096	$515,000	—	30 Sep 2016	13F
Swiss National Bank	13F	Company	0.01%	15,300	$392,000	—	30 Sep 2016	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	14,212	$364,000	—	30 Sep 2016	13F
TEACHERS ADVISORS, LLC	13F	Company	0.01%	13,814	$354,000	—	30 Sep 2016	13F
Neuberger Berman Group LLC	13F	Company	0.01%	13,000	$333,000	—	30 Sep 2016	13F
CITADEL ADVISORS LLC	13F	Company	0.01%	9,303	$238,000	—	30 Sep 2016	13F
ELLINGTON MANAGEMENT GROUP LLC	13F	Company	0.01%	9,117	$233,000	—	30 Sep 2016	13F
RHUMBLINE ADVISERS	13F	Company	0.01%	8,192	$210,000	—	30 Sep 2016	13F
STRS OHIO	13F	Company	0.01%	8,100	$207,000	—	30 Sep 2016	13F
METROPOLITAN LIFE INSURANCE CO/NY	13F	Company	0.01%	8,061	$206,000	—	30 Sep 2016	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.01%	7,520	$192,000	—	30 Sep 2016	13F
Nationwide Fund Advisors	13F	Company	0%	5,747	$147,000	—	30 Sep 2016	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0%	5,195	$133,044	—	30 Sep 2016	13F
BLACKROCK ADVISORS LLC	13F	Company	0%	4,550	$117,000	—	30 Sep 2016	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	3,266	$84,000	—	30 Sep 2016	13F
LADENBURG THALMANN FINANCIAL SERVICES INC.	13F	Company	0%	3,200	$82,000	—	30 Sep 2016	13F

Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS) as of Q4 2016

As of 31 Dec 2016, Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value per share (ACRS) was held by 100 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,351,804 shares. The largest 10 holders included Vivo Capital, LLC, Sofinnova Management VIII, L.L.C., FRANKLIN RESOURCES INC, PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Cormorant Asset Management, LLC, PointState Capital LP, Invesco Ltd., VANGUARD GROUP INC, and FMR LLC. This page lists 100 institutional shareholders reporting positions in this security for the Q4 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2016 vs Q3 2016 Across Filers

Q3 2016 holders

Q4 2016 holders

100

Holder diff

Investor	Q3 2016 Shares	Q4 2016 Shares	Share Diff	Share Chg %	Q3 2016 Value $	Q4 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.